Joint Formulary & PAD

Exemestane - Breast cancer

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important

1st month supply from specialist team before request for primary care prescribing

PAD Profile

ChemicalSubstance :
Exemestane
Indication :
Breast cancer
Group Name :
Keywords :
Aromatase Inhibitors
Brand Names Include :
Aromasin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Exemestane is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Breast cancer.

Committee Recommendations (1)

GENERIC Exemestane has been considered by the PCN and has been assigned an AMBER STAR traffic light status.

NOTE - the branded product, Aromasin, was considered BLACK at the PCN in May 2017.